Toggle navigation
Home
Search
Services
Blog
Contact
About
Isolation of Stage-Specific Markers in Cartilage Tumors
Persinger, Sharon M.
University of Texas MD Anderson Cancer Center, Houston, TX, United States
Search grants from Sharon Persinger
Search grants from University of Texas MD Anderson Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Genetic Factors in Keratoconus
Minority Predoctoral Fellowship Program
Electrophysiology, Drugs of Abuse, and Reward Circuits
Electric Fields on Metabolism of A Chronic Wound Model
Drugs to Treat M Avium Intracellulare Infections
Recently added grants:
Breast Cancer Research Program
Cancer Prevention and Control Research Program
Cancer Epidemiology Research Program
Community Outreach and Engagement
Developmental Funds
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA009368-01
Application #
3034811
Study Section
Biological Sciences 2 (BIOL)
Project Start
1993-02-01
Project End
Budget Start
1992-09-01
Budget End
1993-08-31
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
University of Texas MD Anderson Cancer Center
Department
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Related projects
NIH 1993
F32 CA
Isolation of Stage-Specific Markers in Cartilage Tumors
Persinger, Sharon M. / University of Texas MD Anderson Cancer Center
NIH 1992
F32 CA
Isolation of Stage-Specific Markers in Cartilage Tumors
Persinger, Sharon M. / University of Texas MD Anderson Cancer Center
Publications
Yokoyama, Satoru; Woods, Susan L; Boyle, Glen M et al.
(2011)
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
Nature 480:99-103
Comments
Be the first to comment on Sharon Persinger's grant